Glaxo’s response to Covid has been one of the broadest in the industry with two potential treatments as well as multiple vaccine candidates
Issue: 03 Jun 2021 - Page 17
Shares Magazine
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
